Direct Ingestion of Oxidized Red Blood Cells (Efferocytosis) by Hepatocytes.

ASGPR1 alcohol-related liver disease efferocytosis heme oxygenase-1 iron metabolism red blood cells scavenging receptors

Journal

Hepatic medicine : evidence and research
ISSN: 1179-1535
Titre abrégé: Hepat Med
Pays: New Zealand
ID NLM: 101544801

Informations de publication

Date de publication:
2024
Historique:
received: 29 05 2024
accepted: 14 08 2024
medline: 9 9 2024
pubmed: 9 9 2024
entrez: 9 9 2024
Statut: epublish

Résumé

Both hepatic iron accumulation and hemolysis have been identified as independent prognostic factor in alcohol-related liver disease (ALD); however, the mechanisms still remain poorly understood. We here demonstrate that hepatocytes are able to directly ingest aged and ethanol-primed red blood cells (RBCs), a process termed efferocytosis. Efferocytosis of RBCs was directly studied in vitro and observed by live microscopy for real-time visualization. RBCs pretreated with either CuSO As shown by live microscopy, oxidized RBCs, but not intact RBCs, are rapidly ingested by both Huh7 cells and murine primary hepatocytes within 10 minutes. In some cases, more than 10 RBCs were seen within hepatocytes, surrounding the nucleus. RBC efferocytosis also rapidly induces We here demonstrate that hepatocytes can directly ingest and degrade oxidized RBCs through efferocytosis, a process that can be also triggered by ethanol, heme and bilirubin. Our findings are highly suggestive for a novel mechanism of hepatic iron overload in ALD patients.

Identifiants

pubmed: 39247515
doi: 10.2147/HMER.S469990
pii: 469990
pmc: PMC11380495
doi:

Types de publication

Journal Article

Langues

eng

Pagination

65-77

Informations de copyright

© 2024 Zheng et al.

Déclaration de conflit d'intérêts

Dr Seddik Hammad reports grants from The Stiftung für Biomedizinische Alkoholforschung, the BMBF (German Federal Ministry of Education and Research) Project LiSyM (Grant PTJ-FKZ: 031L0043) and LiSyM-Cancer (Grant PTJ-FKZ: 031L0257A), outside the submitted work. The authors report no other conflicts of interest in this work.

Auteurs

Chaowen Zheng (C)

Center for Alcohol Research, University of Heidelberg, Heidelberg, Germany.
Division of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.

Siyuan Li (S)

Center for Alcohol Research, University of Heidelberg, Heidelberg, Germany.

Huanran Lyu (H)

Center for Alcohol Research, University of Heidelberg, Heidelberg, Germany.

Cheng Chen (C)

Center for Alcohol Research, University of Heidelberg, Heidelberg, Germany.

Johannes Mueller (J)

Center for Alcohol Research, University of Heidelberg, Heidelberg, Germany.

Anne Dropmann (A)

Molecular Hepatology Section, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.

Seddik Hammad (S)

Molecular Hepatology Section, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
Department of Forensic Medicine and Veterinary Toxicology, Faculty of Veterinary Medicine, South Valley University, Quena, Egypt.

Steven Dooley (S)

Molecular Hepatology Section, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.

Songqing He (S)

Division of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.

Sebastian Mueller (S)

Center for Alcohol Research, University of Heidelberg, Heidelberg, Germany.
Viscera AG Bauchmedizin, Bern, Switzerland.

Classifications MeSH